Virtus ETF Advisers LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$78,651
-21.6%
8,624
-9.0%
0.05%
-18.6%
Q2 2023$100,298
+6.7%
9,480
+23.4%
0.06%
+13.5%
Q1 2023$93,988
-28.8%
7,685
-27.7%
0.05%
-24.6%
Q4 2022$131,980
+26.9%
10,635
+39.0%
0.07%
+68.3%
Q3 2022$104,000
-25.2%
7,650
+0.8%
0.04%
-21.2%
Q2 2022$139,000
-31.5%
7,592
-39.8%
0.05%
-42.9%
Q1 2022$203,000
+8.6%
12,601
-5.6%
0.09%
+28.2%
Q4 2021$187,000
+10.0%
13,354
+46.9%
0.07%
-5.3%
Q3 2021$170,000
-15.0%
9,091
-5.0%
0.08%
-8.5%
Q2 2021$200,000
-2.4%
9,572
+31.7%
0.08%
-5.7%
Q1 2021$205,000
-12.0%
7,268
+1.8%
0.09%
-10.3%
Q4 2020$233,000
-59.8%
7,136
-62.3%
0.10%
-68.1%
Q3 2020$579,000
+65.4%
18,907
-12.0%
0.30%
+83.1%
Q2 2020$350,000
+44.6%
21,479
-11.7%
0.17%
+66.0%
Q1 2020$242,000
-36.8%
24,329
-12.7%
0.10%
+58.7%
Q4 2019$383,000
+85.9%
27,872
+105.5%
0.06%
+50.0%
Q3 2019$206,000
-27.0%
13,566
-5.3%
0.04%
-28.8%
Q2 2019$282,000
-12.7%
14,322
-26.3%
0.06%
-91.4%
Q1 2019$323,000
+4.9%
19,441
-11.5%
0.69%
+1196.2%
Q4 2018$308,000
-30.8%
21,970
-13.6%
0.05%
+15.2%
Q3 2018$445,000
-44.0%
25,438
-41.7%
0.05%
-93.4%
Q2 2018$794,000
-23.4%
43,633
-21.1%
0.70%
-22.0%
Q1 2018$1,037,000
+164.5%
55,283
+115.5%
0.90%
+82.9%
Q4 2017$392,00025,6480.49%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders